"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

MAY 10, 2019

PHARMATEST ATTENDS IO CONGRESS AND ARRANGES SEMINAR IN LONDON

Pharmatest attends the 4th Annual Advances in Immuno-oncology Congress arranged by Oxford Global Conferences in London on May 20 – 21, and arranges a seminar titled “Example Studies in Immunodeficient and Humanized Mouse Models and Considerations for Drug Development” in London on May 23 together with Valirx Plc.

Pharmatest Services is a CRO that offers preclinical efficacy services in the fields of oncology and skeletal diseases. In oncology Pharmatest has been the global leading expert in bone metastasis models since 2005.

 In the 4th Annual Advances in Immuno-oncology Congress, Pharmatest has a booth and the following scientific presentations by Research Director Tiina Kähkönen:

-       Oral presentation “Importance Of Microenvironment In Evaluating IO Therapy Response– Case Examples From Bone Metastasis Models In Humanized Mice

-       Poster presentation “Syngeneic bone metastasis models for testing efficacy of novel therapies

-       Poster presentation “Human Immune System Engrafted Mouse Models of Triple-Negative and Triple-Positive Breast Cancer for Preclinical Validation of Novel Immuno-Oncology Therapies

In the seminar “Example Studies in Immunodeficient and Humanized Mouse Models and Considerations for Drug Development” Pharmatest will present bone metastasis models established in humanized mice.

Pharmatest welcomes everyone to attend the free seminar and networking event after it. You can find more information about the seminar and register in the following link: Oncology seminar registration.